Trial intelligence / Profile preview

Propranolol for PTSD

NCT00648375Phase 4Terminated

Sponsor
Weill Cornell Medicine
Start
Dec 2003
Primary completion
Jun 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of propranolol in post-traumatic stress disorder (PTSD), sponsored by Weill Cornell Medicine. Started Dec 2003; status: terminated.

02

Drugs

propranolol
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NCT00648375.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00648375.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call